×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.46 | 91.0 |
| Triochem Products Ltd., | NA | NA | NA | NA | 0 | |
| VISTA PHARMACEUTICALS LTD. | NA | NA | NA | NA | 70.4 | |
| Concord Drugs Limited | NA | NA | NA | NA | 70 | 163.0 |
| Aspira Pathlab & Diagnostics L | NA | NA | NA | NA | 63.7 | 24.9 |
Vista Pharmaceuticals Ltd., with Security Code 524711, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.0 | 1.0 | 2.0 | 3.5 | 1.7 | 3.1 | 1.8 | 2.5 | 2.6 | 3.2 |
| Expenses | 0.3 | 2.4 | 2.9 | 4.6 | 3.5 | 2.9 | 2.6 | 3.3 | 4.1 | 4.1 |
| Operating Profit | -0.3 | -1.4 | -0.9 | -1.2 | -1.7 | 0.3 | -0.8 | -0.8 | -1.5 | -0.9 |
| OPM % | 0% | -136.95% | -46.49% | -33.66% | -102.35% | 8.43% | -43.23% | -32.99% | -59.33% | -27.21% |
| Other Income | 0.0 | 0.3 | 0.1 | 0.1 | 0.0 | 0.1 | 0.1 | 0.0 | 0.1 | 0.2 |
| Interest | 0.4 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.2 | 0.2 |
| Depreciation | 0.2 | 1.1 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 |
| Profit before tax | -0.9 | -2.5 | -1.3 | -1.6 | -2.2 | -0.1 | -1.2 | -1.3 | -1.8 | -1.0 |
| Tax % | 8.1% | 95% | -26% | 27.1% | -26% | -192.9% | -26.8% | -22.2% | -26.7% | 0% |
| Net Profit | -1.0 | -3.9 | -1.0 | -2.0 | -1.6 | 0.1 | -0.9 | -1.0 | -1.3 | -1.5 |
| EPS in Rs | -0.15 | -0.61 | -0.3 | -0.34 | -0.26 | 0.01 | -0.15 | -0.07 | 0 |
No Consolidated data available.
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 2% |
| 5 Years: | -20% |
| 3 Years: | 100% |
| TTM: | 40% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 38% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 3% |
| 3 Years: | 17% |
| 1 Year: | -13% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| 1 Year: | 0% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|